KILBANE CATHERINE M 4

What Happened

• Catherine M. Kilbane, a director of Andersons, Inc. (ANDE), converted/exercised derivative awards to acquire 3,376 shares and received equity awards on May 7, 2026. The filing shows an acquisition of 3,376 shares via exercise/conversion (price reported $0.00) and awards of 39.089 shares and 1,746 restricted share units (RSUs). No cash consideration or dollar value for the derivative transactions is reported.

Key Details

• Transaction date: 2026-05-07; Form 4 filed: 2026-05-08 (timely).
• Reported prices/values: acquisitions listed at $0.00 (for the 3,376 share exercise and one award) and other derivative items shown as N/A in the filing.
• Shares owned after the transaction: not specified in the provided filing data.
• Footnotes of note:
  • F1: 39.089 shares were shares issued in lieu of a cash dividend (dividend equivalents).
  • F2: Each disclosed restricted share unit (RSU) equals the right to receive one share upon vesting.
  • F3: RSUs granted May 8, 2025 (vest one year from grant).
  • F4: RSUs granted May 7, 2026 (vest one year from grant).
• No sale reported; the "disposed" derivative line appears to reflect conversion/settlement of a derivative award rather than an open‑market sale.

Context

• The filing documents conversion/settlement of derivative awards (exercise/conversion) into common shares and new RSU grants. RSUs are not immediately tradable—they convert to shares only upon vesting (here, generally one year after the grant dates noted). Shares issued in lieu of dividends are dividend equivalents and are routine corporate actions rather than an active buy/sell decision by the insider.